About Pulse Biosciences (NASDAQ:PLSE)
Pulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. NPES provides treatment in a range of dermatology and aesthetic applications. It offers treatment for minimally invasive applications, such as cardiac ablation, lung disease, Barret's esophagus, thyroid nodules, and ear, nose and throat (ENT) papillomas. The Company is developing a system for the delivery of NPES treatments, identified as the PulseTx system (PulseTx). The PulseTx system delivers NPES pulses through its tunable pulse generator and its planned suite of electrodes. The PulseTx system pulses are applied directly to tissue through electrodes, creating transient nanometer pores in cell and organelle membranes.
Industry, Sector and Symbol
Industry MED PRODS
Trailing P/E Ratio-7.60814264244069
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Book Value$1.90 per share
Price / Book6.85
Return on Equity-69.38%
Return on Assets-63.74%
Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions
What is Pulse Biosciences' stock symbol?
Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."
How were Pulse Biosciences' earnings last quarter?
Pulse Biosciences Inc (NASDAQ:PLSE) released its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.52) earnings per share (EPS) for the quarter. View Pulse Biosciences' Earnings History.
Who are some of Pulse Biosciences' key competitors?
Some companies that are related to Pulse Biosciences include SurModics (SRDX), Insys Therapeutics (INSY), Accuray (ARAY), Quanterix (QTRX), Endologix (ELGX), Utah Medical Products (UTMD), Antares Pharma (ATRS), Oxford Immunotec Global (OXFD), Pacific Biosciences of California (PACB), RTI Surgical (RTIX), GenMark Diagnostics (GNMK), Rockwell Medical (RMTI), Evolus (EOLS), Quotient (QTNT), Chimerix (CMRX), Fluidigm (FLDM), T2 Biosystems (TTOO) and Cogentix Medical (CGNT).
When did Pulse Biosciences IPO?
(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.
Has Pulse Biosciences been receiving favorable news coverage?
News stories about PLSE stock have trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pulse Biosciences earned a news sentiment score of 0.21 on Accern's scale. They also assigned news coverage about the company an impact score of 46.18 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Pulse Biosciences' major shareholders?
Pulse Biosciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.02%), Citadel Advisors LLC (2.07%), TIAA CREF Investment Management LLC (0.13%), Deutsche Bank AG (0.12%), Millennium Management LLC (0.08%) and Alliancebernstein L.P. (0.06%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.
Which major investors are selling Pulse Biosciences stock?
PLSE stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. and TIAA CREF Investment Management LLC. Company insiders that have sold Pulse Biosciences company stock in the last year include Robert J Greenberg and Thierry B Thaure. View Insider Buying and Selling for Pulse Biosciences.
Which major investors are buying Pulse Biosciences stock?
PLSE stock was bought by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Millennium Management LLC, Deutsche Bank AG, Alliancebernstein L.P., Brown Advisory Inc., Fore Capital LLC, The Manufacturers Life Insurance Company and Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Pulse Biosciences stock in the last two years include Maky Zanganeh, Mitchell E Levinson and Robert W Duggan. View Insider Buying and Selling for Pulse Biosciences.
How do I buy shares of Pulse Biosciences?
Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pulse Biosciences' stock price today?
One share of PLSE stock can currently be purchased for approximately $13.01.
How big of a company is Pulse Biosciences?
Pulse Biosciences has a market capitalization of $248.74 million. The company earns $-25,570,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Pulse Biosciences employs 13 workers across the globe.
How can I contact Pulse Biosciences?
Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 650-697-3939 or via email at [email protected]
MarketBeat Community Rating for Pulse Biosciences (PLSE)MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pulse Biosciences (NASDAQ:PLSE) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Earnings History and Estimates Chart
Pulse Biosciences (NASDAQ PLSE) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Pulse Biosciences (NASDAQ:PLSE) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Pulse Biosciences (NASDAQ:PLSE)
No dividend announcements for this company have been tracked by MarketBeat.com
Pulse Biosciences (NASDAQ PLSE) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 6.70%
Institutional Ownership Percentage: 11.19%
Pulse Biosciences (NASDAQ PLSE) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/12/2017||Maky Zanganeh||Director||Buy||4,000||$23.07||$92,280.00||332,500|| |
|10/19/2017||Robert W Duggan||Major Shareholder||Buy||22,901||$22.79||$521,913.79||5,820,513|| |
|9/24/2017||Robert W Duggan||Major Shareholder||Buy||2,000,000||$15.02||$30,040,000.00||5,797,612|| |
|9/18/2017||Maky Zanganeh||Director||Buy||29,775||$13.36||$397,794.00||315,725|| |
|9/18/2017||Robert W Duggan||Major Shareholder||Buy||409,918||$14.36||$5,886,422.48||3,437,994|| |
|9/14/2017||Mitchell E Levinson||Director||Buy||3,835||$12.30||$47,170.50|| |
|8/3/2017||Maky Zanganeh||Director||Buy||28,790||$23.96||$689,808.40||287,225|| |
|8/3/2017||Robert W Duggan||Major Shareholder||Buy||277,450||$23.14||$6,420,193.00||3,153,234|| |
|8/2/2017||Maky Zanganeh||Director||Buy||8,290||$25.15||$208,493.50||287,225|| |
|5/23/2017||Robert W Duggan||Major Shareholder||Buy||83,928||$26.86||$2,254,306.08||3,054,244|| |
|5/22/2017||Robert W Duggan||Major Shareholder||Buy||34,728||$26.25||$911,610.00||3,054,244|| |
|5/12/2017||Thierry B Thaure||Director||Sell||10,000||$24.40||$244,000.00||10,000|| |
|5/11/2017||Robert W Duggan||Major Shareholder||Buy||43,389||$21.04||$912,904.56||2,984,227|| |
|5/10/2017||Robert J Greenberg||Director||Sell||25,000||$21.12||$528,000.00||25,000|| |
|5/8/2017||Thierry B Thaure||Director||Sell||15,000||$22.49||$337,350.00||15,000|| |
|4/28/2017||Robert W Duggan||Major Shareholder||Buy||84,348||$23.88||$2,014,230.24||2,958,579|| |
|4/27/2017||Robert W Duggan||Major Shareholder||Buy||35,387||$24.79||$877,243.73||2,923,379|| |
|4/19/2017||Robert W Duggan||Major Shareholder||Buy||150,123||$23.77||$3,568,423.71||2,601,850|| |
|4/18/2017||Robert W Duggan||Major Shareholder||Buy||61,819||$25.49||$1,575,766.31||2,601,850|| |
|4/17/2017||Robert W Duggan||Major Shareholder||Buy||107,300||$24.81||$2,662,113.00||2,601,850|| |
|4/10/2017||Robert W. Duggan||Major Shareholder||Buy||191,464||$19.75||$3,781,414.00|| |
|3/20/2017||Maky Zanganeh||Director||Buy||18,240||$23.34||$425,721.60||263,935|| |
|3/18/2017||Robert W Duggan||Major Shareholder||Buy||205,127||$23.56||$4,832,792.12||2,174,479|| |
Pulse Biosciences (NASDAQ PLSE) News Headlines
|Pulse Biosciences Grants Equity Incentive Awards to New Employees - Business Wire (press release)|
www.businesswire.com - March 21 at 4:37 PM
|Pulse Biosciences Grants Equity Incentive Awards to New Employees|
finance.yahoo.com - March 21 at 4:37 PM
|Pulse Biosciences' (PLSE) CEO Darrin Uecker on Q4 2017 Results ... - Seeking Alpha|
seekingalpha.com - March 18 at 5:18 PM
|Pulse Biosciences Quarterly Investor Conference Call|
finance.yahoo.com - March 16 at 5:32 PM
|Is Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Incentives Align With Yours?|
finance.yahoo.com - March 16 at 9:38 AM
|Pulse Biosciences (PLSE) and Agilent Technologies (A) Financial Contrast|
www.americanbankingnews.com - March 8 at 2:07 PM
|Pulse Biosciences (PLSE) Scheduled to Post Quarterly Earnings on Monday|
www.americanbankingnews.com - March 5 at 2:34 AM
|Pulse Biosciences (PLSE) versus Cynosure (CYNO) Head-To-Head Survey|
www.americanbankingnews.com - February 24 at 9:12 PM
|BidaskClub Lowers Pulse Biosciences (PLSE) to Strong Sell|
www.americanbankingnews.com - February 18 at 1:00 PM
|Pulse Biosciences (PLSE) Lifted to "Hold" at ValuEngine|
www.americanbankingnews.com - February 4 at 5:35 PM
|Financial Comparison: Pulse Biosciences (PLSE) vs. Its Competitors|
www.americanbankingnews.com - January 31 at 11:16 AM
|Critical Contrast: Pulse Biosciences (PLSE) and The Competition|
www.americanbankingnews.com - January 31 at 11:16 AM
|Pulse Biosciences Inc (PLSE) Sees Significant Decrease in Short Interest|
www.americanbankingnews.com - January 30 at 2:44 PM
|Comparing Illumina (ILMN) & Pulse Biosciences (PLSE)|
www.americanbankingnews.com - January 29 at 5:14 PM
|Pulse Biosciences (PLSE) vs. Reshape Lifesciences (RSLS) Head-To-Head Contrast|
www.americanbankingnews.com - January 28 at 9:26 AM
|Head to Head Survey: Pulse Biosciences (PLSE) vs. The Competition|
www.americanbankingnews.com - January 27 at 5:20 PM
|Head to Head Analysis: Pulse Biosciences (PLSE) & Its Rivals|
www.americanbankingnews.com - January 23 at 9:28 PM
|Reviewing Pulse Biosciences (PLSE) and The Competition|
www.americanbankingnews.com - January 20 at 7:50 PM
|Pulse Biosciences (PLSE) & Its Competitors Head-To-Head Contrast|
www.americanbankingnews.com - January 17 at 5:15 PM
|Pulse Biosciences (PLSE) vs. Its Peers Head-To-Head Comparison|
www.americanbankingnews.com - January 16 at 1:10 PM
|Contrasting Pulse Biosciences (PLSE) and Its Peers|
www.americanbankingnews.com - January 14 at 5:34 PM
|Critical Comparison: Pulse Biosciences (PLSE) and Its Competitors|
www.americanbankingnews.com - January 12 at 9:06 AM
|Analyzing Pulse Biosciences (PLSE) & Its Peers|
www.americanbankingnews.com - January 12 at 8:04 AM
|Pulse Biosciences (PLSE) & The Competition Critical Analysis|
www.americanbankingnews.com - January 11 at 11:46 AM
|Pulse Biosciences (PLSE) and Luna Innovations (LUNA) Critical Analysis|
www.americanbankingnews.com - January 10 at 9:46 AM
|Head to Head Review: Pulse Biosciences (PLSE) and The Competition|
www.americanbankingnews.com - January 9 at 11:04 AM
|Pulse Biosciences (PLSE) and Its Peers Head to Head Analysis|
www.americanbankingnews.com - January 8 at 3:30 AM
|Analyzing Pulse Biosciences (PLSE) & Its Competitors|
www.americanbankingnews.com - January 3 at 11:30 PM
|Pulse Biosciences (PLSE) Upgraded to Hold at ValuEngine|
www.americanbankingnews.com - January 1 at 12:52 PM
|Biotech Forum Daily Digest: Why We Are Passing On Pulse - Seeking Alpha|
seekingalpha.com - December 29 at 4:38 PM
|Pulse Biosciences (PLSE) Rating Increased to Hold at BidaskClub|
www.americanbankingnews.com - December 29 at 8:46 AM
|Pulse Biosciences (PLSE) Stock Rating Lowered by BidaskClub|
www.americanbankingnews.com - December 23 at 12:34 PM
|Pulse Biosciences, Inc (PLSE) Short Interest Down 3.5% in November|
www.americanbankingnews.com - December 18 at 4:36 PM
|Pulse Biosciences (PLSE) Upgraded to Hold by BidaskClub|
www.americanbankingnews.com - December 16 at 12:02 PM
|Pulse Biosciences Grants Equity Inducement Awards to New Employees|
finance.yahoo.com - December 16 at 10:15 AM
|Does Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Pay Reflect Performance?|
finance.yahoo.com - December 14 at 10:22 AM
|Pulse Biosciences, Inc (PLSE) Director Acquires $92,280.00 in Stock|
www.americanbankingnews.com - December 13 at 11:38 PM
|Pulse Biosciences Quarterly Investor Conference Call - Business Wire (press release)|
www.businesswire.com - November 9 at 11:39 AM
|Pulse Biosciences, Inc. to Host Earnings Call|
finance.yahoo.com - November 9 at 11:39 AM
|Pulse Biosciences Quarterly Investor Conference Call|
finance.yahoo.com - November 9 at 11:39 AM
|Pulse Biosciences, Inc (PLSE) Issues Quarterly Earnings Results|
www.americanbankingnews.com - November 8 at 3:02 PM
|Pulse Biosciences, Inc (PLSE) to Release Earnings on Monday|
www.americanbankingnews.com - November 6 at 2:14 AM
|Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017|
finance.yahoo.com - October 25 at 9:10 AM
|Commit To Purchase Pulse Biosciences At $17.50, Earn 17.5% Annualized Using Options - TheStreet.com|
www.thestreet.com - October 24 at 8:36 AM
|Insider Buying: Pulse Biosciences, Inc (PLSE) Major Shareholder Buys 22,901 Shares of Stock|
www.americanbankingnews.com - October 23 at 7:28 PM
|Four Tampa Bay billionaires make the Forbes 400|
www.bizjournals.com - October 19 at 7:35 AM
|Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE)|
finance.yahoo.com - October 16 at 2:31 AM
|Tracking Pre-Clinical Data in Biotech: Risk Versus Reward - PR Newswire (press release)|
www.prnewswire.com - October 5 at 9:39 PM
|Pulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock|
www.streetinsider.com - September 27 at 6:00 PM
|Pulse Biosciences, Inc (PLSE) Major Shareholder Purchases $30,040,000.00 in Stock|
www.americanbankingnews.com - September 26 at 7:24 PM
Pulse Biosciences (NASDAQ:PLSE) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Pulse Biosciences (NASDAQ:PLSE) Income Statement, Balance Sheet and Cash Flow Statement
Pulse Biosciences (NASDAQ PLSE) Stock Chart for Friday, March, 23, 2018